Answers are grounded in this paper and cite their sources.
This review highlights biodegradable polymeric nanoparticles' effects on long-term prostate cancer treatment, suggesting a smarter, non-invasive approach.
Prostate cancer is still one of the most popular diseases with a high mortality rate all over the world, so that more efficient treatment approaches are extremely required, and polymeric-based nanoparticles may represent a more non-invasive smart carrier that can increase selectivity and reduce adverse reactions in addition to the possibility for a more prolonged drug release profile. This review aims to highlight the role of biodegradable polymeric-based nanoparticles as a potential platform for long-term prostate cancer treatment.
No takes yet. Share an insight, caveat, or question.
Basam Mahmoud Kasem (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: